Pages that link to "Q39617721"
Jump to navigation
Jump to search
The following pages link to Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma (Q39617721):
Displaying 30 items.
- EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (Q27000343) (← links)
- Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management (Q27024076) (← links)
- Methotrexate and Pralatrexate (Q28083080) (← links)
- T-cell lymphomas, a challenging disease: types, treatments, and future. (Q30244553) (← links)
- Analysis of methylation and mRNA expression status of FADD and FAS genes in patients with oral squamous cell carcinoma. (Q34654092) (← links)
- c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death (Q35071772) (← links)
- Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues (Q35124821) (← links)
- Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression (Q35835628) (← links)
- Epigenetic biomarkers in skin cancer (Q36080974) (← links)
- Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate (Q36255777) (← links)
- Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management (Q36470196) (← links)
- Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells (Q36568751) (← links)
- Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation (Q36628909) (← links)
- Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management (Q37944565) (← links)
- Targeting the Fas/FasL signaling pathway in cancer therapy. (Q37975245) (← links)
- Cutaneous T-cell lymphomas: a review of new discoveries and treatments (Q37981969) (← links)
- NFκB function and regulation in cutaneous T-cell lymphoma (Q38162229) (← links)
- DNA methylation and apoptosis resistance in cancer cells (Q38202821) (← links)
- Sézary Syndrome: Clinical and Biological Aspects (Q38814744) (← links)
- Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma (Q38841211) (← links)
- Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy (Q38991433) (← links)
- SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis (Q39042777) (← links)
- Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis (Q39150709) (← links)
- Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study (Q50853522) (← links)
- Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors (Q50938874) (← links)
- c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases (Q51349220) (← links)
- Epigenetically Enhanced PDT (ePDT) Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of CTCL. (Q52575394) (← links)
- Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma (Q59794233) (← links)
- In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells (Q61798312) (← links)
- Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy (Q90101887) (← links)